Willdan Group Reports Third Quarter Results

Willdan reported Q3 2026 contract revenue of $214.5 million, up 17.9%, and net revenue of $112.2 million, up 18.1%. Adjusted EBITDA rose 22.4% to $28.3 million, while net income fell 13.6% to $11.9 million; GAAP diluted EPS declined 15.6% to $0.76 and adjusted diluted EPS edged down 0.8% to $1.20.

Analysis

The key signal is not top-line growth but the widening gap between operating and shareholder-level performance: adjusted EBITDA rose while GAAP net income and diluted EPS fell, and adjusted EPS was nearly flat. That argues against extrapolating the revenue acceleration directly into per-share earnings. The missing bridge is material: review the GAAP-to-adjusted reconciliation, share-count changes, interest expense, taxes, and cash conversion before underwriting margin expansion or treating the GAAP decline as merely nonrecurring. The excerpt also truncates the nine-month comparison, so it does not support a clean year-to-date read-through.

Near term, the mixed scorecard leaves room for a volatile but non-directional reaction; there is not enough evidence here to establish whether the result beats expectations or changes valuation. Over the next 1–3 months, the catalyst is management’s explanation of the EPS/EBITDA divergence and any update to backlog, project conversion, or full-year outlook. Over 6–18 months, durable upside depends on converting higher activity into cash earnings per share, not simply sustaining contract growth. A reversal would be indicated by weaker subsequent revenue or EBITDA, falling backlog/conversion, or guidance that reveals the gap is structural rather than timing-related. The contrarian risk is that investors may over-credit adjusted EBITDA while overlooking dilution or below-the-line costs; equally, one quarter’s GAAP decline may overstate deterioration if clearly identified items explain it.

Key Decisions for Investors

• Do not initiate a directional WLDN position from this excerpt alone. First compare results with consensus and inspect the earnings release’s adjustment reconciliation, diluted share count, operating cash flow, and guidance.
• For existing holders, treat the EBITDA/GAAP divergence as a diligence flag, not yet a sell signal. Reassess if follow-up disclosure shows persistent per-share earnings weakness or poor cash conversion despite continued EBITDA growth.
• Set a 1–3 month alert for backlog, project conversion, and full-year outlook commentary. Upgrade the thesis only if growth translates into stronger GAAP EPS and cash generation; downgrade it if margins, conversion, or guidance weaken.
• No options or peer pair is warranted without valuation, consensus, balance-sheet, and comparable-company data. Those inputs are needed to judge whether the mixed earnings profile is already priced in.